Skip to content
Catalyst

luteinFinding

Lutein inhibits CCN2

lowersInsufficient evidenceFinding

01 · The sentence it was drawn from

“LU inhibited ACTA2, COL1A1, FN1, and CTGF mRNA expression and suppressed α-SMA, and FN1 protein expression induced by TGF-β1.”
Quoted verbatim from Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy.
This finding among the 1 finding on its endpoint

lutein

CCN2

inhibits

Who
orbital fibroblasts from patients with thyroid-associated ophthalmopathy, treated with TGF-β1 to induce fibrosis
Dose studied
not reported

Insufficient evidencePMID 37207866 · 2023

02 · The study

Study
in vitro · not in humans
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3J8H2MMRD8Z3VFSK8R5ABJ9